We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-8.16%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.58B
AUM Growth
-$140M
Cap. Flow
+$56.9M
Cap. Flow %
3.61%
Top 10 Hldgs %
87.3%
Holding
43
New
3
Increased
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
ASTS icon
AST SpaceMobile
ASTS
+$229M
2
MTSR
Metsera Inc
MTSR
+$141M
3
MAZE
Maze Therapeutics
MAZE
+$29M

Top Sells

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$206M
2
CRWD icon
CrowdStrike
CRWD
+$135M
3
BHIL
Benson Hill, Inc.
BHIL
+$864K

Sector Composition

Rank Sector Weight
1 Technology 55.05%
2 Healthcare 37.76%
3 Industrials 7.19%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRSH icon
1
Freshworks
FRSH
$2.84B
$229M 14.5%
16,206,643
ARM icon
2
Arm
ARM
$278B
$209M 13.28%
1,960,784
ASTS icon
3
AST SpaceMobile
ASTS
$16.8B
$203M 12.9%
+8,943,486
New +$229M
RVMD icon
4
Revolution Medicines
RVMD
$40.2B
$146M 9.27%
4,133,277
MTSR
5
DELISTED
Metsera Inc
MTSR
$135M 8.56%
+4,961,744
New +$141M
GTLB icon
6
GitLab
GTLB
$5.28B
$128M 8.12%
2,724,712
-3,366,526
-55% -$206M
PL icon
7
Planet Labs
PL
$7.3B
$108M 6.85%
31,942,641
TEM
8
Tempus AI
TEM
$7.69B
$74.8M 4.74%
1,551,102
PATH icon
9
UiPath
PATH
$5.62B
$72.5M 4.59%
7,034,337
DXCM icon
10
DexCom
DXCM
$27.6B
$70.8M 4.49%
1,036,937
VERV
11
DELISTED
Verve Therapeutics
VERV
$56.4M 3.58%
12,349,086
PRME icon
12
Prime Medicine
PRME
$533M
$30M 1.9%
15,062,498
MAZE
13
Maze Therapeutics
MAZE
$1.53B
$26.6M 1.68%
+2,412,471
New +$29M
CRWD icon
14
CrowdStrike
CRWD
$187B
$26.2M 1.66%
296,920
-1,414,660
-83% -$135M
GLUE icon
15
Monte Rosa Therapeutics
GLUE
$1.92B
$6.79M 0.43%
1,464,015
OSCR icon
16
Oscar Health
OSCR
$8.5B
$6.32M 0.4%
481,988
BEAM icon
17
Beam Therapeutics
BEAM
$2.58B
$6.28M 0.4%
321,604
VERA icon
18
Vera Therapeutics
VERA
$2.54B
$5.8M 0.37%
241,264
DM
19
DELISTED
Desktop Metal, Inc.
DM
$5.42M 0.34%
1,104,871
SANA icon
20
Sana Biotechnology
SANA
$885M
$4.72M 0.3%
2,812,500
RLAY icon
21
Relay Therapeutics
RLAY
$4.02B
$4.11M 0.26%
1,568,753
DNTH icon
22
Dianthus Therapeutics
DNTH
$5.68B
$3.79M 0.24%
208,697
LYEL icon
23
Lyell Immunopharma
LYEL
$309M
$3.17M 0.2%
293,256
WGS icon
24
GeneDx Holdings
WGS
$1.75B
$2.01M 0.13%
22,711
FHTX icon
25
Foghorn Therapeutics
FHTX
$285M
$1.83M 0.12%
500,901

Similar funds

Alphabet Inc's Q1 2025 Portfolio in Review

As of Q1 2025, Alphabet Inc held 43 positions worth $1.58B, down 8.2% from $1.72B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Alphabet Inc deployed $56.9M of net new capital in Q1 2025, opening 3 new positions. Its largest new stake was AST SpaceMobile: 8,943,486 shares worth $203M.

By sector, the portfolio is most concentrated in Technology at 55% of assets, down from 63% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was GitLab, an estimated $206M trimmed.

  • Alphabet Inc's largest Q1 2025 buy was AST SpaceMobile: 8,943,486 shares worth $203M.
  • Alphabet Inc's biggest Q1 2025 reduction was GitLab, cutting an estimated $206M.
  • Alphabet Inc fully exited Benson Hill, Inc. in Q1 2025, selling an estimated $864K.
  • Alphabet Inc's ten largest holdings make up 87% of its $1.58B portfolio in Q1 2025.
  • Alphabet Inc opened 3 new positions and closed 3 in Q1 2025.
  • Alphabet Inc's portfolio value fell 8.2% quarter-over-quarter to $1.58B.

Based on Alphabet Inc's 13F filing for Q1 2025, filed 2 May 2025.